Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Merck
Federal Trade Commission
Deloitte
Daiichi Sankyo
AstraZeneca
Argus Health
Healthtrust

Generated: October 15, 2018

DrugPatentWatch Database Preview

Alra Company Profile

« Back to Dashboard

What is the competitive landscape for ALRA, and what generic and branded alternatives to ALRA drugs are available?

ALRA has twenty-four approved drugs.



Summary for Alra
US Patents:0
Tradenames:17
Ingredients:15
NDAs:24

Drugs and US Patents for Alra

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra SOXAZOLE sulfisoxazole TABLET;ORAL 080366-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alra DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 080519-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alra BAMATE meprobamate TABLET;ORAL 080380-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alra GEN-XENE clorazepate dipotassium TABLET;ORAL 071788-001 Apr 26, 1988 AB RX No No ➤ Sign Up ➤ Sign Up
Alra HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 086369-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Alra IBU-TAB ibuprofen TABLET;ORAL 071965-001 Aug 11, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Harvard Business School
US Army
Express Scripts
Baxter
Covington
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.